Dizziness

Medicine

Volumn 36, Issue 10, 2008, Pages 535-539

  Murdin, Louisa ^a   Davies, Rosalyn ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

benign positional paroxysmal vertigo; dizziness; electronystagmography; Hallpike test; M ni re's disease; migraine; neurology; peripheral vestibular dysfunction; vertigo; vestibular rehabilitation

Indexed keywords

AMINOGLYCOSIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BACLOFEN; BETAHISTINE; CISPLATIN; CLONAZEPAM; DEXAMETHASONE; DIURETIC AGENT; GABAPENTIN; METHYLPREDNISOLONE; PLACEBO; PROCHLORPERAZINE; SCOPOLAMINE; SEDATIVE AGENT; SEROTONIN 1B ANTAGONIST; SEROTONIN 1D ANTAGONIST; THIAZIDE DIURETIC AGENT; TRANQUILIZER;

ANAMNESIS; BALANCE DISORDER; BENIGN PAROXYSMAL POSITIONAL VERTIGO; BLOOD PRESSURE MEASUREMENT; BODY POSITION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIZZINESS; DROWSINESS; ELECTRONYSTAGMOGRAPHY; EYE MOVEMENT; HEARING LOSS; HEARING TEST; HUMAN; KINESIOTHERAPY; LOW DRUG DOSE; MENIERE DISEASE; MIGRAINE; MOTION SICKNESS; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; OTOTOXICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PURE TONE AUDIOMETRY; REVIEW; SEDATION; SIDE EFFECT; SODIUM RESTRICTION; STABILOGRAPHY; TINNITUS; VERTIGO; VESTIBULAR DISORDER;

EID: 53049086980     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2008.07.012     Document Type: Review

References (14)

1. Davis A., Smith P., Ferguson M., Stephens D., and Gianopoulos I. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess 11 Suppl 42 (2007) 5-53
2. von Brevern M., Radtke A., Lezius F., et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 78 (2007) 710-715
3. Neuhauser H.K., Radtke A., von Brevern M., et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 67 (2006) 1028-1033
4. Guerraz M., Yardley L., Bertholon P., et al. Visual vertigo: symptom assessment, spatial orientation and postural control. Brain 124 (2001) 1646-1656
5. Furman J.M., Marcus D.A., and Balaban C.D. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16 (2003) 5-13
6. Halmagyi G.M., and Curthoys I.S. A clinical sign of canal paresis. Arch Neurol 45 (1988) 737-739
7. Strupp M., Zingler V.C., Arbusow V., et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 351 (2004) 354-361
8. Spinks A.B., Wasiak J., Villanueva E.V., and Bernath V. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 3 (2007) CD002851
9. Kisilevsky V., Einarson T.R., Kozer E., Koren G., Rutka J.A., and Cohen-Kerem R. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope 114 (2004) 2085-2091
10. Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 116 (2006) 1782-1786
11. Hillier S.L., and Hollohan V. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 4 (2007) CD005397
12. Bamiou D.E., Davies R.A., McKee M., and Luxon L.M. Symptoms, disability and handicap in unilateral peripheral vestibular disorders. Effects of early presentation and initiation of balance exercises. Scand Audiol 29 (2000) 238-244
13. Pavlou M., Lingeswaran A., Davies R.A., Gresty M.A., and Bronstein A.M. Simulator based rehabilitation in refractory dizziness. J Neurol 251 (2004) 983-995
14. Strupp M., and Brandt T. Pharmacological advances in the treatment of neuro-otological and eye movement disorders. Curr Opin Neurol 19 (2006) 33-40